Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin
Authors:
- 8 January 2008
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 114 (3) , 251-256
Abstract
Free radical production is increased during diabetes. Serum albumin is a major antioxidant agent, and structural modification of albumin induced by glucose or free radicals impairs its antioxidant properties. Therefore the aim of the present study was to compare the antioxidant capacities and structural changes in albumin in patients with T2DM (Type 2 diabetes mellitus) treated with MET (metformin) or SU (sulfonylureas) and in healthy control subjects. Structural changes in albumin were studied by fluorescence quenching in the presence of acrylamide. Albumin thiols and fructosamines, reflecting oxidized and glycation-induced changes in serum albumin respectively, were assessed. Structural changes in albumin were demonstrated by a significant decrease in fluorescence quenching in patients with T2DM, with patients treated with MET exhibiting a significant difference in the conformation of albumin compared with patients treated with SU. Oxidation, resulting in a significant decrease in thiol groups and plasma total antioxidant capacity, and glycation, associated with a significant increase in fructosamines, were both found when comparing healthy control subjects with patients with T2DM. When patients treated with MET were compared with those treated with SU, oxidative stress and glycation were found to be significantly lower in MET-treated patients. In conclusion, patients with T2DM have a decrease in the antioxidant properties of serum albumin which may aggravate oxidative stress and, thus, contribute to vascular and metabolic morbidities. Moreover, a significant protection of albumin was found in patients with T2DM treated with MET.Keywords
This publication has 26 references indexed in Scilit:
- Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase CBiochemical Pharmacology, 2006
- Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapyDiabetologia, 2006
- Advanced Glycation End Products Are Associated With Pulse Pressure in Type 1 DiabetesHypertension, 2005
- Albumin antioxidant capacity is modified by methylglyoxalDiabetes & Metabolism, 2005
- Metformin inhibition of glycation processesDiabetes & Metabolism, 2003
- An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stressMetabolism, 2003
- Metformin decreases platelet superoxide anion production in diabetic patientsDiabetes/Metabolism Research and Reviews, 2002
- An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.Diabetes, 1999
- Antioxidant Potential of Anaerobic Human Plasma: Role of Serum Albumin and Thiols as Scavengers of Carbon RadicalsArchives of Biochemistry and Biophysics, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993